Monte Rosa Therapeutics (GLUE) Other Gross PP&E Adjustments (2023 - 2025)
Historic Other Gross PP&E Adjustments for Monte Rosa Therapeutics (GLUE) over the last 3 years, with Q3 2025 value amounting to $28.1 million.
- Monte Rosa Therapeutics' Other Gross PP&E Adjustments rose 2535.52% to $28.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.1 million, marking a year-over-year increase of 2535.52%. This contributed to the annual value of $23.0 million for FY2024, which is 3351.12% up from last year.
- According to the latest figures from Q3 2025, Monte Rosa Therapeutics' Other Gross PP&E Adjustments is $28.1 million, which was up 2535.52% from $26.8 million recorded in Q2 2025.
- Monte Rosa Therapeutics' Other Gross PP&E Adjustments' 5-year high stood at $28.1 million during Q3 2025, with a 5-year trough of $13.5 million in Q2 2023.
- In the last 3 years, Monte Rosa Therapeutics' Other Gross PP&E Adjustments had a median value of $21.6 million in 2024 and averaged $20.7 million.
- Per our database at Business Quant, Monte Rosa Therapeutics' Other Gross PP&E Adjustments soared by 5920.97% in 2024 and then surged by 2340.17% in 2025.
- Monte Rosa Therapeutics' Other Gross PP&E Adjustments (Quarter) stood at $17.2 million in 2023, then skyrocketed by 33.51% to $23.0 million in 2024, then rose by 21.9% to $28.1 million in 2025.
- Its last three reported values are $28.1 million in Q3 2025, $26.8 million for Q2 2025, and $24.4 million during Q1 2025.